Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Celloop - Centrifugal Perfusion Gut-on-Chip: A Scalable, Pump-Free Platform for Predictive Drug Testing and Preclinical Innovation

Project description

Low-cost Centrifugal Perfusion Gut-on-Chip alternative for drug absorption studies

The Centrifugal Perfusion Gut-on-Chip (CPGoC) system uses centrifugal force for continuous perfusion, mimicking fluid flow and nutrient transport in the human intestine. This eliminates the need for external pumps and tubing, reducing costs and contamination risks. In this context, the ERC-funded Celloop-CPGoC project aims to validate the CPGoC system, a low-cost, pump-free, and user-friendly alternative for drug absorption studies. This system addresses the limitations of outdated static cultures and the high costs of microfluidic organ chips. By providing an affordable and relevant model, CPGoC could accelerate drug discovery, reduce development costs, and streamline regulatory approval processes, thereby revolutionising drug testing.

Objective

This project aims to validate the Centrifugal Perfusion Gut-on-Chip (CPGoC) system, offering a low-cost, pump-free, and user-friendly alternative to existing microfluidic systems for drug absorption studies. Unlike traditional models, CPGoC uses centrifugal force to drive continuous perfusion, closely mimicking physiological fluid flow and nutrient transport in the human intestine. Thus, it eliminates the need for external pumps and tubing, reducing costs, contamination risks, and technical barriers.
Our system is designed to bridge the gap between outdated static cultures and overpriced, complex microfluidic organ chips. By offering an affordable, easy-to-use, and physiologically relevant alternative, CPGoC will accelerate drug discovery, reduce development costs, and shorten development time. CPGoC has the potential to revolutionize drug testing, providing researchers with a more accessible and predictive model to improve human drug evaluation and regulatory approval processes.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

DANMARKS TEKNISKE UNIVERSITET
Net EU contribution
€ 150 000,00
Address
ANKER ENGELUNDS VEJ 101
2800 Kongens Lyngby
Denmark
Region
Danmark Hovedstaden Københavns omegn
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)